TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/21 15:02 | 2/8/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | M.d | 315 | 11.60 | 0 | 27 | 24 | D | ||||||||||||||||
2/9/21 15:02 | 2/8/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | S.d | -464 | 28.16 | 0 | -16 | -40 | 24 | D | |||||||||||||||
2/26/20 08:51 | 2/24/20 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | P | 23 | 7.52 | 0 | 3 | 33 | 12 | D | |||||||||||||||
5/23/19 12:59 | 5/22/19 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | P | 23 | 11.26 | 0 | 2 | 50 | 6 | D | |||||||||||||||
11/21/18 13:46 | 11/20/18 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | M.d | 27 | 13.55 | 0 | 2 | 200 | 3 | D | |||||||||||||||
2/7/18 15:57 | 2/7/18 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rice John McCune Jr. | OH | D | P | 15 | 14.75 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |